Alembic Pharmaceuticals announces its first product approval from its Formulation Division IV, Jarod Facility
Alembic Pharmaceuticals Ltd has received PAS approval from the US Food & Drug Administration for its sANDA Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg.
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Us Food Drug Administration Formulation Division Pharmaceuticals Limited Prior Approval Supplement
Source: equitybulls.com